$590.83
0.41% day before yesterday
NYSE, Nov 28, 09:30 pm CET

Thermo Fisher Scientific Stock price

$590.83
+33.20 5.95% 1M
+188.70 46.93% 6M
+70.60 13.57% YTD
+69.17 13.26% 1Y
+50.80 9.41% 3Y
+125.85 27.07% 5Y
+452.43 326.90% 10Y
+560.13 1,824.53% 20Y
NYSE, Closing price Fri, Nov 28 2025
-2.42 0.41%

New AI Insights on Thermo Fisher Scientific Insights AI Insights on Thermo Fisher Scientific

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$222.9b
Enterprise Value
$255.0b
Net debt
$32.1b
Cash
$3.5b
Shares outstanding
377.6m
Valuation (TTM | estimate)
P/E
34.1 | 25.8
P/S
5.1 | 5.0
EV/Sales
5.8 | 5.7
EV/FCF
41.7
P/B
4.4
Dividends
DPS
$1.72
Yield 1Y | 5Y
0.3% | 0.3%
Growth 1Y | 5Y
10.3% | 14.3%
Payout 1Y | 3Y
9.4% | 8.4%
Increased
8 Years
Financials (TTM | estimate)
Revenue
$43.7b | $44.7b
EBITDA
$8.5b | $11.1b
EBIT
$8.0b | $10.0b
Net Income
$6.6b | $8.7b
Free Cash Flow
$6.1b
Growth (TTM | estimate)
Revenue
3.2% | 4.3%
EBITDA
-20.0% | 2.5%
EBIT
8.7% | 29.6%
Net Income
7.1% | 36.9%
Free Cash Flow
-21.4%
Margin (TTM | estimate)
Gross
41.4%
EBITDA
19.4% | 24.8%
EBIT
18.4%
Net
15.0% | 19.4%
Free Cash Flow
14.0%
Financial Health
Equity Ratio
51.0%
Return on Equity
12.8%
ROCE
9.1%
ROIC
-
Debt/Equity
0.7
More
EPS
$17.4
FCF per Share
$16.2
Short interest
1.5%
Employees
125k
Rev per Employee
$340.0k
Show more

Is Thermo Fisher Scientific a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,070 stocks worldwide.

Thermo Fisher Scientific Stock Analysis

Unlock Scores for Free

Analyst Opinions

32 Analysts have issued a Thermo Fisher Scientific forecast:

25x Buy
78%
7x Hold
22%

Analyst Opinions

32 Analysts have issued a Thermo Fisher Scientific forecast:

Buy
78%
Hold
22%

Financial data from Thermo Fisher Scientific

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
43,736 43,736
3% 3%
100%
- Direct Costs 25,618 25,618
2% 2%
59%
18,118 18,118
5% 5%
41%
- Selling and Administrative Expenses 8,220 8,220
3% 3%
19%
- Research and Development Expense 1,414 1,414
5% 5%
3%
8,484 8,484
20% 20%
19%
- Depreciation and Amortization 435 435
86% 86%
1%
EBIT (Operating Income) EBIT 8,049 8,049
9% 9%
18%
Net Profit 6,570 6,570
7% 7%
15%

In millions USD.

Don't miss a Thing! We will send you all news about Thermo Fisher Scientific directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Thermo Fisher Scientific Stock News

Neutral
Business Wire
4 days ago
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that it has priced an offering of €2.1 billion aggregate principal amount (the “Offering”) of the following euro-denominated notes, which will be issued by Thermo Fisher Scientific (Finance I) B.V., its indirect, wholly-owned finance subsidiary: €1,000,000,000 aggregate principal amount ...
Neutral
Business Wire
8 days ago
CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, has received approval from the U.S. Food and Drug Administration (FDA) for its Ion Torrent™ Oncomine™ Dx Target Test as a companion diagnostic (CDx) to identify patients who may be eligible for treatment with HYRNUO™ (sevabertinib), a new HER2-directed therapy developed and commercialized by Bayer....
Positive
MarketBeat
9 days ago
A common strategy among retail investors is to mirror the investment moves of successful firms and market leaders. Poring over the Form 13-F results of gurus like Warren Buffett can reveal valuable insights, albeit on a delayed schedule.
More Thermo Fisher Scientific News

Company Profile

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

Head office United States
CEO Marc Casper
Employees 125,000
Founded 1960
Website corporate.thermofisher.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today